To further investigate the reason for the high expression of S100A4 in cytarabine-resistant AML cells, we found that NR6A1 could directly bind to the S100A4 promoter region to achieve enhanced transcription by analyzing multiple transcription factors. The gene discussed is NR6A1; the disease is acute myeloid leukemia.